Supernus Pharmaceuticals Cash from Operations TTM:
-47.20M for Dec. 31, 2012Supernus Pharmaceuticals Historical Cash from Operations TTM Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -47.20M |
| Sept. 30, 2012 | -39.32M |
| June 30, 2012 | -37.12M |
| March 31, 2012 | -36.45M |
| Dec. 31, 2011 | -36.18M |
About Cash From Operations (TTM)
SUPN Cash from Operations TTM Benchmarks
| Companies | |
|---|---|
| Catalyst Pharmaceutical Partners | -5.140M |
| MEI Pharma | -8.224M |
| Keryx Biopharmaceuticals | -24.76M |
SUPN Cash from Operations TTM Rankings
| Overall |
37th percentile 4718 of 7593 |
| Sector |
15th percentile 550 of 650 in Healthcare |
| Industry |
15th percentile 55 of 65 in Drug Manufacturers - Specialty & Generic |
SUPN Cash from Operations TTM Range, Past 5 Years
| Minimum | -47.20M | Dec 2012 |
| Maximum | -36.19M | Dec 2011 |
| Average | -39.25M |
SUPN News
Supernus (SUPN) PT Trimmed at Jefferies, But Survey Shows Significant Market Opportunity
Street Insider May 17
Street Insider May 17